Medicus Pharma Ltd. — Director's Dealing 2025

Jul 4, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2025-06-30

Reporting Person: Smith Andrew Alasdair (Chief Operating Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.60	2030-06-30	Common Shares (100000)		Direct

Footnotes

F1: The options vest annually in five equal installments beginning on June 30, 2026.